Atlas Trials

Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations

Clinical trial NCT03764722 · UNKNOWN

Trial details

NCT number
NCT03764722
Sponsor
Collegium Medicum w Bydgoszczy
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Systolic Heart Failure
Start date
2018-08-01
Primary completion
2021-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.